![](/img/cover-not-exists.png)
2008 POSTER The E-ZO-FAST trial: Zoledronic acid (ZA) effectively inhibits aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant Letrozole (Let)
N. Schenk, A. Lombart, A. Frassoladti, P. Neven, G. Jerusalem, I. Deleu, J. Mebis, M. Maerevoet, J. Miller, R. DiasVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70770-x
File:
PDF, 84 KB
english, 2007